ClearPoint Neuro, Inc. - Common Stock (CLPT)

CUSIP: 18507C103

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock
Shares outstanding
28,354,279
Total 13F shares
992,026
Share change
-102,882
Total reported value
$5,416,000
Price per share
$5.46
Number of holders
25
Value change
-$335,510
Number of buys
9
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 18507C103?
CUSIP 18507C103 identifies CLPT - ClearPoint Neuro, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CLPT - ClearPoint Neuro, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
1.6%
455,038
$1,618,000 30 Jun 2020
13F
PARSONS CAPITAL MANAGEMENT INC/RI
13F
Company
0.53%
151,584
$539,000 30 Jun 2020
13F
Worth Venture Partners, LLC
13F
Company
0.27%
76,361
$272,000 30 Jun 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.18%
50,600
$180,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
0.18%
49,872
$177,000 30 Jun 2020
13F
Merriman Wealth Management, LLC
13F
Company
0.17%
47,690
$170,000 30 Jun 2020
13F
Mayo Clinic
13F
Company
0.17%
47,148
$168,000 30 Jun 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.15%
43,067
$155,000 30 Jun 2020
13F
KIRR MARBACH & CO LLC /IN/
13F
Company
0.15%
42,200
$150,000 30 Jun 2020
13F
BROWN ADVISORY INC
13F
Company
0.1%
28,000
$100,000 30 Jun 2020
13F
Parkman Healthcare Partners LLC
13F
Company
0.09%
25,078
$89,000 30 Jun 2020
13F
SILVERCREST ASSET MANAGEMENT GROUP LLC
13F
Company
0.08%
23,700
$84,000 30 Jun 2020
13F
Williams Jones Wealth Management, LLC.
13F
Company
0.08%
21,552
$77,000 30 Jun 2020
13F
IEQ CAPITAL, LLC
13F
Company
0.07%
20,000
$71,000 30 Jun 2020
13F
WESTWOOD MANAGEMENT CORP /IL/
13F
Company
0.06%
17,500
$62,000 30 Jun 2020
13F
REGIONS FINANCIAL CORP
13F
Company
0.04%
11,655
$41,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
0.04%
11,053
$39,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
10,849
$38,000 30 Jun 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
3,456
$12,000 30 Jun 2020
13F
Moisand Fitzgerald Tamayo, LLC
13F
Company
0.01%
2,216
$8,000 30 Jun 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
1,500
$5,000 30 Jun 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
1,000
$4,000 30 Jun 2020
13F
ROYAL BANK OF CANADA
13F
Company
0%
500
$2,000 30 Jun 2020
13F
OPTIMUM INVESTMENT ADVISORS
13F
Company
0%
437
$2,000 30 Jun 2020
13F

Institutional Holders of ClearPoint Neuro, Inc. - Common Stock (CLPT) as of Q3 2020

As of 30 Sep 2020, ClearPoint Neuro, Inc. - Common Stock (CLPT) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 992,026 shares. The largest 10 holders included VANGUARD GROUP INC, PARSONS CAPITAL MANAGEMENT INC/RI, BlackRock Inc., Merriman Wealth Management, LLC, KIRR MARBACH & CO LLC /IN/, RENAISSANCE TECHNOLOGIES LLC, BROWN ADVISORY INC, MILLENNIUM MANAGEMENT LLC, SILVERCREST ASSET MANAGEMENT GROUP LLC, and Williams Jones Wealth Management, LLC.. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
24
Q3 2020 holders
25
Holder diff
1
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .